Treatment
Medical treatment clinical trials
We’re tracking 1,134 recruiting studies that include Medical treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07351955Recruiting
New brain stimulation study for children with tic disorders
This trial tests a personalized, non-invasive brain stimulation method for children aged 5 to 18 with tic disorders who haven't been treated before. It aims to see if this new approach can help reduce tics safely.
Shanghai, Shanghai MunicipalityAges 5 months–18 years - NCT07529145Recruiting
Heart and Lung Fitness Testing During Lung Cancer Treatment
This study measures how well your heart and lungs work before and during lung cancer treatment using an exercise test. The goal is to understand how cancer treatment affects your physical fitness and help doctors better monitor your health.
Bialystok, Podlaskie VoivodeshipAges 18 years+ - NCT06026943Recruiting
Alpha radiation therapy for locally advanced pancreatic cancer
This trial tests a new treatment that uses tiny alpha radiation sources placed directly into the tumor to destroy cancer cells. It is for people with pancreatic cancer that has not spread but cannot be removed surgically, and who have already tried at least one type of chemotherapy or cannot take more chemo.
VeronaAges 18–120 - NCT04815668Recruiting
Acupuncture for moderate-to-severe seasonal allergy rhinitis
This trial tests whether acupuncture at a specific spot behind the nose can reduce symptoms from seasonal allergies (triggered by things like grass or birch pollen). It may help if your allergy symptoms are moderate to severe and have lasted for a long time.
BeijingAges 18–75 - NCT07216703RecruitingPhase 3
Study of sacituzumab tirumotecan plus pembrolizumab for cervical cancer
This trial tests a combination of two drugs (sacituzumab tirumotecan and pembrolizumab) as a first maintenance treatment for cervical cancer that has spread or come back. It is for people who haven't had other cancer treatments for this stage and whose tumors have a certain protein marker (PD-L1).
Fort Myers, FloridaAges 18 years+ - NCT06422845Recruiting
Drug-coated balloon for dialysis fistula narrowing
This trial tests a special balloon that releases medication to help keep your dialysis fistula (the blood vessel used for treatment) open longer if it has narrowed. It may be a good option if you have a blockage in the vein side of your fistula that causes problems during dialysis.
Hefei, AnhuiAges 18–80 - NCT06613113Recruiting
Fruquintinib, adebrelimab, and radiation for advanced colorectal cancer
This trial tests a combination of two drugs (fruquintinib and adebrelimab) plus low or high dose radiation for people with advanced colorectal cancer that has not responded to standard treatments. The goal is to see if this combination can shrink tumors or slow the disease.
Ningbo, ZhejiangAges 18 years+ - NCT07387952Recruiting
Fecal transplant with nutrition help for chronic constipation
This trial tests if a fecal microbiota transplant combined with nutritional support can improve chronic constipation that hasn't gotten better with standard treatments. It's a small early study to see if the approach is safe and works.
BeijingAges 18–70 - NCT04561206RecruitingPhase 2
Brentuximab plus nivolumab for relapsed Hodgkin lymphoma
This Phase 2 trial studies brentuximab vedotin plus nivolumab in people whose classical Hodgkin lymphoma has come back or did not respond to treatment. It aims to shrink tumors and improve control of the disease, especially when standard options like transplant are not possible.
Duarte, CaliforniaAges 18 years+ - NCT06503692Recruiting
Comparing balloons for dialysis graft narrowing
This trial tests two types of balloon catheters (scoring and high-pressure) to open up narrowed spots in dialysis grafts. The goal is to find which works better to keep your access working well for dialysis.
Beijing, Beijing MunicipalityAges 18–80 - NCT05354375RecruitingPhase 1
PSMA-targeted CAR-T cell therapy for resistant prostate cancer
This Phase 1 study tests whether lab-made immune cells (CAR-T) that target PSMA can treat prostate cancer that keeps growing despite hormone treatment. It may help people whose disease no longer responds to standard endocrine (hormone-blocking) therapy.
Xuzhou, JiangsuAges 18–75 - NCT07034742RecruitingEarly Phase 1
MRD testing after stomach cancer surgery
This study looks at whether a blood test for leftover cancer cells (called MRD) after stomach cancer surgery can help guide treatment. It is for people with a certain type of stomach cancer that has spread to nearby tissues but not to distant organs, and who are having surgery as their first treatment.
BeijingAges 18–75 - NCT07254169Enrolling by invitation
Herbal medicine for post-accident fatigue
This trial tests if a special herbal medicine treatment can help people who still feel very tired after a traffic accident. It aims to see if the treatment is safe and effective for reducing fatigue.
Seoul, Gangnam-GuAges 40–69 - NCT05826743Recruiting
Check a new alternative to ileostomy after bowel surgery
This trial tests whether a device called COLO-BT can be a safer, effective alternative to an ileostomy (a temporary or longer-term opening from the intestine to the skin). It’s for certain adults having a bowel connection low in the pelvis, where leak risk matters.
Buffalo, New YorkAges 19–80 - NCT05066633RecruitingPhase 3
Metoprolol added to standard care to prevent heart muscle damage
This trial tests whether adding metoprolol (a beta-blocker) to usual care can prevent or slow cardiomyopathy (heart muscle weakness) in people with Duchenne muscular dystrophy (DMD). It also checks for safety, especially effects on heart rate and rhythm.
Gdansk, Pomeranian VoivodeshipAges 8–17 - NCT05093374RecruitingPhase 4
AI-guided care for wet age-related macular degeneration
This Phase 4 study tests an artificial-intelligence (AI) system used in real-world care for people with “wet” age-related macular degeneration. The goal is to help doctors monitor and treat the eye more accurately and safely over time.
Vienna, State of ViennaAges 50–100 - NCT05445011RecruitingPhase 1
FLT3-targeted CAR-T for relapsed or resistant AML
This trial tests an engineered immune cell treatment (CAR-T) made to target FLT3, for adults with acute myeloid leukemia (AML) that has come back or did not respond to standard treatment. It aims to control the leukemia when options have been limited.
Wuhan, HubeiAges 18–70 - NCT05587569Recruiting
Foot surgery outcomes study for bunion and forefoot alignment
This trial studies results after a combined bunion and forefoot alignment surgery to improve foot shape and function. It may help people whose foot angles show significant bunion and front-of-foot deformity.
Greeley, ColoradoAges 14–65 - NCT05977231Recruiting
Conservative care for women’s urine leakage problems
This trial looks at how well non-surgical treatments help women with urinary incontinence (urine leakage). You may be eligible if you’re able to follow up regularly for at least a year and plan to stay with conservative, non-surgical care.
New Taipei CityAges 20–100 - NCT06341907RecruitingPhase 2/Phase 3
Vaccine and blood test to prevent ovarian cancer return
This trial tests a personalized vaccine for people with epithelial ovarian cancer who still have a small amount of cancer DNA in their blood after surgery. The goal is to see if the vaccine can help stop the cancer from coming back.
Wenzhou, ZhejiangAges 18–70 - NCT07561073Recruiting
Two surgical approaches for blocked stomachs in advanced gastric cancer
This study compares two different surgical methods to relieve stomach blockage caused by advanced gastric cancer that cannot be removed with standard surgery. The goal is to help patients eat and feel better by restoring food flow through the stomach.
Nanning, GuangxiAges 18–75 - NCT06685887RecruitingPhase 2
Chemo, Immunotherapy, and Heated Belly Chemo for Stomach Cancer Spread
This trial tests combining standard chemotherapy and immunotherapy (tirelizumab) with heated chemotherapy given directly into the belly. It aims to treat stomach cancer that has spread to the abdominal lining, and may help shrink or control the cancer.
Wuhan, HubeiAges 18–75 - NCT06549426Recruiting
Treating seizure activity after cardiac arrest
This trial tests a treatment for seizure-like brain activity that can happen after a cardiac arrest. It aims to see if treating these seizures quickly can improve recovery for people who are in a coma.
BrusselsAges 18 years+ - NCT07243184Recruiting
Polymer heart valve study for mitral valve disease
This trial is testing a new polymer artificial heart valve for people with severe mitral valve problems. It aims to see if this valve is safe and works well during surgical replacement.
BeijingAges 60 years+
Common questions
- Are there clinical trials studying Medical treatment?
- Yes. Clin2 currently lists 1,134 recruiting studies that include Medical treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medical treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medical treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medical treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.